Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer

BACKGROUND: Advanced gastric cancer has an unfavorable prognosis and poor curability. Immune checkpoint inhibitors, such as nivolumab, have recently emerged as a potential solution for this aggressive disease. However, there is a lack of established evidence on the clinical efficacy of these agents,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Chen, Yamauchi, Suguru, Yube, Yukinori, Egawa, Hiroki, Yoshimoto, Yutaro, Kubota, Akira, Tsuda, Kenki, Kaji, Sanae, Orita, Hajime, Oka, Shinichi, Mine, Shinji, Fukunaga, Tetsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199150/
https://www.ncbi.nlm.nih.gov/pubmed/37204618
http://dx.doi.org/10.1186/s40792-023-01668-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199150/
https://www.ncbi.nlm.nih.gov/pubmed/37204618
http://dx.doi.org/10.1186/s40792-023-01668-x

Ejemplares similares